Elucidating the activation mechanism of botulinum neurotoxin a: role of α-clostripain and NTNH. [PDF]
Pitel S +8 more
europepmc +1 more source
Microfluidic Nanobiosensor Detection of Botulinum Neurotoxin Serotype A. [PDF]
Srinivasan S +6 more
europepmc +1 more source
Immunological Considerations of Polysorbate as an Excipient in Botulinum Neurotoxin Type A Formulations: A Narrative Review. [PDF]
Martin MU +5 more
europepmc +1 more source
RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage. [PDF]
Batista AF +5 more
europepmc +1 more source
A translational preclinical strategy for chronic spinal cord injury: neuroprotective and regenerative potential of botulinum neurotoxin type A combined with muscle atrophy prevention via electrostimulation. [PDF]
Mastrorilli V +17 more
europepmc +1 more source
Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted from Mouse Parasympathetic Ganglionic Junctions Paralysed with Botulinum Neurotoxin Type A. [PDF]
Al-Sabi A, Lawrence GW.
europepmc +1 more source
Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes. [PDF]
Liao Y +6 more
europepmc +1 more source
Cell-Penetrating Botulinum Neurotoxin Type A Proteins Alleviate Skeletal Muscle Hypertrophy with Associated Alterations of Mitochondrial Homeostasis. [PDF]
Li L, Wei X, Jiang L, Gao Z, Liu J.
europepmc +1 more source
Related searches:
Botulinum Neurotoxins: Mechanism of Action
Toxicon, 2013Botulinum neurotoxins are used clinically for conditions characterized by hyperexcitability of peripheral nerve terminals and hypersecretory syndromes. These neurotoxins are synthesized as precursor proteins with low activity, but their effects are mediated by the active form of the neurotoxin through a multistep mechanism.
Giampietro Schiavo
exaly +3 more sources

